HCV patients post chemotherapy Mean ± SD | HCV patients without cancer Mean ± SD | p-value | ||
---|---|---|---|---|
ALT (IU/L) | 58.6 ± 37.36 | 58.7 ± 102.6 | 0.993 | |
AST (IU/L) | 59.6 ± 31.8 | 54.2 ± 55.6 | 0.440 | |
Baseline HCV RNA × log 10 | 5.63 ± 0.91 | 5.54 ± 0.95 | 0.63 | |
AFP (U/L) | 10.8 ± 16.86 | 9.7 ± 15.13 | 0.712 | |
Albumin (g/dl) | 4.02 ± 0.65 | 3.99 ± 0.90 | 0.76 | |
Total bilirubin (mg/dl) | 0.80 ± 0.40 | 1.06 ± 1.17 | 0.048 | |
Indirect bilirubin (mg/dl) | 0.51 ± 0.42 | 0.50 ± 0.28 | 0.98 | |
TSH | 2.23 ± 1.8 | 1.74 ± 1.08 | 0.15 | |
WBC × 103 mm3 | 6.04 ± 3.98 | 7.13 ± 10.46 | 0.37 | |
ANC × 103 mm3 | 4.07 ± 8.21 | 6.51 ± 12.23 | 0.23 | |
Hb (g/l) | 13.22 ± 1.85 | 12.94 ± 1.50 | 0.27 | |
Platelets × 103 mm3 | 173.8 ± 71.8 | 184.83 ± 82.4 | 0.35 | |
PC% | 84.81 ± 16.36 | 86.37 ± 10.52 | 0.537 | |
INR | 1.12 ± 0.16 | 1.10 ± 0.13 | 0.38 | |
Creatinine (mg/dl) | 0.86 ± 0.26 | 0.91 ± 0.79 | 0.54 | |
Glucose (mg/dl) | 107.15 ± 31.66 | 109.52 ± 30.73 | 0.66 | |
HbA1C% | 6.34 ± 1.09 | 7.32 ± 1.46 | 0.013 | |
Liver ultrasound known cirrhotic | N (%) 17 (20.5%) | N (%) 12 (13.6%) | Total 29 (17%) | 0.233 |
Liver stiffness (Kpa) | 15.28 ± 8.12 | 23.78 ± 16.77 | 0.28 | |
FIB-4 calculation | 3.14 ± 2.47 | 2.95 ± 3.06 | 0.655 |